A New Protein Target for Controlling Diabetes
April 11, 2013
…target for treating dysfunctional beta cells and type 2 diabetes, a disease affecting more than 25 million Americans.
Your search for “Diabetes” returned 402 results
Clinical Trial To Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes
September 9, 2014
Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
Type 2 Diabetes Alters the Behavior of Discs in the Vertebral Column
February 13, 2024
Type 2 diabetes alters the behavior of discs in the vertebral column, making them stiffer, and also causes the discs to change shape earlier than normal. As a result, the disc’s ability to withstand pressure is compromised.
Clinical Trial Tests Tattoo Sensor as Needleless Glucose Monitor for Diabetes Patients
April 19, 2018
…Needleless Glucose Monitor for Diabetes Patients Dr. Edward Chao is the principal investigator of a phase I clinical trial testing the accuracy of a needleless glucose monitor developed by University of California San Diego Jacobs School of Engineering researchers that adheres to the skin like a temporary tattoo to read…
Step Up: Walking May Reduce Type 2 Diabetes Risk for Adults 65 and Older
January 20, 2022
UC San Diego Herbert Wertheim School of Public Health study reports that the more steps taken, and the more intense, the lower the risk of Type 2 diabetes among women 65 and older.
Cocoa May Enhance Skeletal Muscle Function
March 2, 2012
…that patients with advanced heart failure and type 2 diabetes showed improved mitochondrial structure after three months of treatment with epicatechin-enriched cocoa. Epicatechin is a flavonoid found in dark chocolate.
UC San Diego Receives $9 Million in Grants to Pinpoint Cellular Cause of Type 1 Diabetes
August 13, 2019
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.
Diabetes in a Dish
October 1, 2014
…Institutes of Health to advance treatments for type 1 diabetes. Using human stem cells, the team plans to culture bits of human pancreas in a dish and, using microfluidics, mimic blood flow through the islet.
The Connection Between Oxygen and Diabetes
June 5, 2014
Researchers at the University of California, San Diego School of Medicine have, for the first time, described the sequence of early cellular responses to a high-fat diet, one that can result in obesity-induced insulin resistance and diabetes. The findings also suggest potential molecular targets for preventing or reversing the process.
UC San Diego Health Nationally Recognized for Stroke and Diabetes Care
August 16, 2023
American Heart Association honors UC San Diego Health with multiple awards for its commitment to treating patients with heart disease and stroke.
